Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENT (Details)

v3.23.2
SUBSEQUENT EVENT (Details)
1 Months Ended
Aug. 15, 2023
USD ($)
installment
Aug. 02, 2023
USD ($)
Aug. 31, 2023
USD ($)
May 31, 2023
$ / shares
shares
Jun. 30, 2023
$ / shares
Mar. 31, 2023
$ / shares
Dec. 31, 2022
$ / shares
Subsequent Event [Line Items]              
Common stock, par value (in dollars per share) | $ / shares         $ 0.001 $ 0.001 $ 0.001
Price per share | $ / shares       $ 1.20      
Note Warrant [Member]              
Subsequent Event [Line Items]              
Underwritten public offering, number of shares | shares       5,000,000      
Price per share | $ / shares       $ 1.199      
Warrant exercise price (in dollars per share) | $ / shares       $ 0.001      
Over-Allotment Option [Member]              
Subsequent Event [Line Items]              
Underwritten public offering, number of shares | shares       750,000      
Subsequent Events | Purchase Agreement with Innovation Neuromonitoring LLC              
Subsequent Event [Line Items]              
Purchase price $ 1,200,000            
Cash payments 200,000 $ 100,000 $ 800,000        
Amount paid in twenty-four equal monthly installments, with the first installment being due on or before September 1, 2023 $ 500,000            
Number of monthly installments | installment 24            
Amount paid in common stock of the Company, which is subject a six month lock-up $ 400,000            
Subsequent Events | Innovation Neuromonitoring LLC [Member]              
Subsequent Event [Line Items]              
Cash payments   $ 131,422.00          
Subsequent Events | Rhythmlink International LLC [Member]              
Subsequent Event [Line Items]              
Cash payments $ 34,000